BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/19/2022 7:32:06 AM | Browse: 670 | Download: 1540
 |
Received |
|
2022-01-31 20:32 |
|
Peer-Review Started |
|
2022-01-31 20:34 |
|
First Decision by Editorial Office Director |
|
2022-04-18 20:57 |
|
Return for Revision |
|
2022-04-18 20:57 |
|
Revised |
|
2022-04-29 12:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-06-22 09:14 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-06-27 00:08 |
|
Articles in Press |
|
2022-06-27 00:08 |
|
Edit the Manuscript by Language Editor |
|
2022-06-08 03:42 |
|
Typeset the Manuscript |
|
2022-06-29 03:09 |
|
Publish the Manuscript Online |
|
2022-07-19 07:32 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Minireviews |
| Article Title |
Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Estela Saez, Leire Erkoreka, Teresa Moreno-Calle, Belen Berjano, Ana Gonzalez-Pinto, Nieves Basterreche and Aurora Arrue |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Leire Erkoreka, MD, PhD, Associate Chief Physician, Department of Psychiatry, Barrualde-Galdakao Integrated Health Organization, Osakidetza-Basque Health Service, Labeaga Auzoa 46A, Galdakao 48960, Spain. leire.erkorekagonzalez@osakidetza.eus |
| Key Words |
Genetics; N-methyl-D-aspartic acid receptor; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; Treatment-resistant depression; Ketamine; Esketamine |
| Core Tip |
Depression is a common mental disorder and one of the leading causes of disability worldwide. Up to 15%-40% of cases are considered treatment-resistant depression, which seems to be conditioned by environmental and genetic factors. The glutamatergic system and, specifically, N-methyl-D-aspartic acid receptor (NMDAR) dysfunction, has been proposed to be involved in the pathogenesis of treatment-resistant depression (TRD). A literature search was performed to identify studies on the genetics of the glutamatergic system in depression, focused on NMDAR and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor. Our review highlights GRIN2B, which encodes the NR2B subunit of NMDAR, as a candidate gene in the pathogenesis of TRD. |
| Publish Date |
2022-07-19 07:32 |
| Citation |
Saez E, Erkoreka L, Moreno-Calle T, Berjano B, Gonzalez-Pinto A, Basterreche N, Arrue A. Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature. World J Psychiatry 2022; 12(7): 884-896 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i7/884.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i7.884 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
